SG/CALL/ABBOTT LABORATORIES/130/0.1/21.06.24 Stock

Warrant

DE000SQ0VUV9

Market Closed - Deutsche Boerse AG 03:40:17 2024-05-16 pm EDT
0.001 EUR 0.00% Intraday chart for SG/CALL/ABBOTT LABORATORIES/130/0.1/21.06.24
1 month-97.78%
3 months-99.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-16 0.001 0.00%
24-05-15 0.001 0.00%
24-05-14 0.001 0.00%
24-05-13 0.001 0.00%
24-05-10 0.001 0.00%

Delayed Quote Deutsche Boerse AG

Last update May 16, 2024 at 03:40 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SQ0VUV
ISINDE000SQ0VUV9
Date issued 2022-09-23
Strike 130 $
Maturity 2024-06-21 (36 Days)
Parity 10 : 1
Emission price 0.77
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.99
Lowest since issue 0.001
Spread 0.021
Spread %95.45%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.6 USD
Average target price
126.1 USD
Spread / Average Target
+20.61%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW